1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. NUTRACEUTICAL INGREDIENTS MARKET BY INGREDIENT TYPE
5.1. Introduction
5.2. Proteins & Amino Acids
5.3. Vitamins & Minerals
5.4. Botanical Extracts
5.5. Probiotics
5.6. Carbohydrates & Specialty Fibres
5.7. Others
6. NUTRACEUTICAL INGREDIENTS MARKET BY SOURCE
6.1. Introduction
6.2. Plant-Based
6.3. Marine
6.4. Animal-Derived
6.5. Microbial
6.6. Mineral
7. NUTRACEUTICAL INGREDIENTS MARKET BY FORM
7.1. Introduction
7.2. Dry/Powder
7.3. Liquid
7.4. Others
8. NUTRACEUTICAL INGREDIENTS MARKET BY APPLICATION
8.1. Introduction
8.2. Dietary Supplements
8.3. Functional Foods
8.4. Functional Beverages
8.5. Animal Nutrition
8.6. Personal Care & Cosmetics
8.7. Pharmaceuticals
9. NUTRACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. Germany
9.4.2. France
9.4.3. United Kingdom
9.4.4. Spain
9.4.5. Others
9.5. Middle East and Africa
9.5.1. Israel
9.5.2. Saudi Arabia
9.5.3. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. Japan
9.6.3. South Korea
9.6.4. India
9.6.5. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Cargill, Incorporated
11.2. BASF SE
11.3. Arla Foods Ingredients Group P/S
11.4. Ajinomoto Co., Inc.
11.5. Evonik Nutrition & Care GmbH
11.6. SPI Pharma
11.7. Aurea Biolabs Pvt. Ltd.
11.8. Martin Bauer Group
11.9. DuPont de Nemours, Inc.
11.10. Wacker Chemie AG
11.11. ADM
11.12. Tata & Lyle
11.13. Kerry Group
11.14. Ingredion Incorporated
11.15. Glanbia plc
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES